CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Purdue Pharma L.P. v. Ranbaxy Inc.

1:11-cv-02401

Overview

Case Number 1:11-cv-02401
Filing Date 2011-04-08
Status Terminated
Termination Date 2013-04-30
Court District Court, S.D. New York (nysd)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Miscellaneous

Mallinckrodt Inc. Operating Company

Represented By

3 Attorneys Listed

Laura Fahey Fritts

Kasowitz, Benson, Torres & Friedman LLP

Tel: +1 (404) 260-6132
Fax: +1 (404) 393-0462

1349 West Peachtree Street, N.W., Suite 1500, Atlanta, GA 30309

Jeffrey James Toney

Sutherland Asbill & Brennan LLP

Tel: +1 (404) 853-8000
Fax: +1 (404) 853-8806

999 Peachtree Street, Ne, Atlanta, GA 30309

Norman E.B. Minnear

Sutherland, Asbill & Brennan, L.L.P.

Tel: +1 (212) 389-5092
Fax: +1 (212) 389-5099

Sutherland, Asbill & Brennan, L.L.P., 1114 Avenue of the Americas

Counter Claimant

Ranbaxy Inc. Operating Company

Represented By

10 Attorneys Listed

Counter Defendant

The P.F. Laboratories, Inc. Operating Company

Represented By

3 Attorneys Listed

Rhodes Technologies NPE (Individual / Inventor)

Represented By

3 Attorneys Listed

Purdue Pharmaceuticals L.P. NPE (University / Research)

Represented By

4 Attorneys Listed

Purdue Pharma L.P. NPE (University / Research)

Represented By

3 Attorneys Listed

Court & Judges

Court

District Court, S.D. New York (nysd)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

No Co-Pending Disputes Detected in Current Index

There are no other active filings for this patent family across our indexed PTAB, U.S. Court, UPC, or EPO databases.

Patents Involved

No asserted patent numbers detected in initial docket filings yet.

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

6

Dispositive

1

Granted

2

Denied

0

Pending / Review

3

Motions by Category

Motion to Dismiss 1 Motion to Compel Discovery 4 Motion to Strike / Sanctions 1

Key Dispositive Motions & Rulings

Motion to Dismiss Granted
ORDER: 1. By consent of the parties, Actavis's third counterclaim in Case No.10 Civ. 3734 is dismissed with prejudice. Accordingly, Purdue's motion to dismiss A...
Entry #23 • 2011-12-27 Document →
Motion to Strike / Sanctions Granted in Part
ORDER finding as moot (171) Motion for Protective Order. ; finding as moot (187) Motion in Limine; granting (189) Motion in Limine; finding as moot (198) Motion...
Entry #80 • 2012-11-14 Document →
Motion to Compel Discovery Granted
ORDER: For the reasons stated on the record at today's pretrial conference, IT IS HEREBY ORDERED THAT: The parties' request to file the proposed pretrial order ...
Entry #56 • 2012-10-22 Document →
Motion to Compel Discovery Pending / Under Review
DECLARATION of Jonathan Bachand in Support re: (109 in 1:10-cv-03734-SHS) MOTION to Compel Purdue Pharma L.P., The P.F. Laboratories, Inc., Purdue Pharmaceutica...
Entry #31 • 2012-01-23 Document →
Motion to Compel Discovery Pending / Under Review
STIPULATION AND ORDER FOR EXTENSION OF TIME TO RESPOND TO PLAINTIFFS' OPPOSITION TO DEFENDANTS RANBAXY INC., RANBAXY PHARMACEUTICALS INC., AND RANBAXY LABORATOR...
Entry #30 • 2012-01-13 Document →
Motion to Compel Discovery Pending / Under Review
ENDORSED LETTER addressed to Judge Sidney H. Stein from William R. Zimmerman dated 1/6/2012 re: I write this letter in response to Pablo D. Hendler's letter on ...
Entry #29 • 2012-01-12 Document →

Docket Entries

(109 total)
Pleading / Complaint

COMPLAINT against Ranbaxy Inc., Ranbaxy Laboratories Ltd., Ranbaxy Pharmaceuticals Inc. (Filing Fee $ 350.00, Receipt Number 1003558)Document filed by Purdue Pharma L.P., Rhodes Technologies, Purdue Pharmaceuticals L.P., The P.F. Laboratories, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(ama) (Entered: 04/11/2011)

Entry #1 • 2011-04-08
1
Pleading / Complaint

COMPLAINT against Ranbaxy Inc., Ranbaxy Laboratories Ltd., Ranbaxy Pharmaceuticals Inc. (Filing Fee $ 350.00, Receipt Number 1003558)Document filed by Purdue Pharma L.P., Rhodes Technologies, Purdue Pharmaceuticals L.P., The P.F. Laboratories, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(ama) (Entered: 04/11/2011)

Entry #1 • 2011-04-08
2
Pleading / Complaint

COMPLAINT against Ranbaxy Inc., Ranbaxy Laboratories Ltd., Ranbaxy Pharmaceuticals Inc. (Filing Fee $ 350.00, Receipt Number 1003558)Document filed by Purdue Pharma L.P., Rhodes Technologies, Purdue Pharmaceuticals L.P., The P.F. Laboratories, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(ama) (Entered: 04/11/2011)

Entry #1 • 2011-04-08
2
Pleading / Complaint

COMPLAINT against Ranbaxy Inc., Ranbaxy Laboratories Ltd., Ranbaxy Pharmaceuticals Inc. (Filing Fee $ 350.00, Receipt Number 1003558)Document filed by Purdue Pharma L.P., Rhodes Technologies, Purdue Pharmaceuticals L.P., The P.F. Laboratories, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(ama) (Entered: 04/11/2011)

Entry #1 • 2011-04-08
2

RULE 7.1 CORPORATE DISCLOSURE STATEMENT. Identifying Purdue Holdings L.P.; Purdue Pharma L.P.; Pharmaceutical Research Associates, Inc.; Rhodes Technologies Inc. as Corporate Parent. Document filed by Purdue Pharma L.P., Purdue Pharmaceuticals L.P., Rhodes Technologies, The P.F. Laboratories, Inc.(ama) (Entered: 04/11/2011)

Entry #2 • 2011-04-08
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc